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ABSTRACT 
We present the case of a patient who underwent cardiac transplantation with the diagnosis of idiopathic dilated 
cardiomyopathy. Once the explanted heart was examined, a type of granulomatous myocarditis compatible with cardiac 
sarcoidosis was observed. However, there was severe involvement of the right ventricle, with markedly reduced width of the 
muscular layer and extensive fibrofatty replacement, findings similar to the ones encountered in cases of arrhythmogenic 
right ventricular cardiomyopathy (ARVC). Confocal immunofluorescence analysis revealed a reduced signal for plakoglobin 
and desmoplakin at the cardiac intercalated disks. The immunoreactive signal for desmin showed the typical sarcomeric 
distribution but not a concentrated signal at the intercalated disks, a pattern previously seen in an 11-year-old girl with 
Carvajal syndrome bearing a C-terminal truncating mutation in the desmoplakin gene. This case illustrates the difficult 
and challenging work involved in performing a differential diagnosis among idiopathic dilated cardiomyopathy, isolated 
cardiac sarcoidosis, and ARVC, all of which are clinical entities known to masquerade as one another. 
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CASE REPORT
A 60-year-old woman presented with exertional 
dyspnea, with mild limitation during ordinary physical 
activities. An electrocardiogram revealed a complete 
left bundle branch block and sinus tachycardia. 
Doppler echocardiography showed a severely dilated 
left ventricle (LV; 61 and 71 mm in systole and 
diastole, respectively), and a mildly dilated left atrium 
(40 mm). The LV ejection fraction (LVEF) was 30%. 
Cardiac catheterization revealed dilatation of the LV, 
and the coronary arteries appeared normal. Chagas 
disease serology was negative. Carvedilol, losartan 
and furosemide were then prescribed, with clinical 
improvement.
The patient had no previous history of smoking 
or alcohol abuse. Her past surgical history included a 
cholecystectomy due to symptomatic biliary lithiasis 
complicated with pancreatitis. She had hypothyroidism 
and used levothyroxin 125 µg per day. Two siblings had 
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been diagnosed with dilated cardiomyopathy, while 
another brother had died suddenly in adolescence.
One year after the onset of symptoms, the patient 
was admitted to the intensive care unit with cardiogenic 
shock, and received dobutamine, with temporary clinical 
improvement. Soon after discharge, she underwent 
cardiac resynchronization therapy due to refractory 
heart failure. Despite this, over the following months she 
presented with additional episodes of cardiogenic shock, 
and became dependent on dobutamine. Two years after 
the onset of symptoms, she was referred to a university 
hospital for cardiac transplantation. Upon clinical 
examination, she had cold extremities, slow capillary 
refilling, arterial hypotension, signs of increased central 
venous pressure, tachycardia, a third heart sound, 
and hepatomegaly. There was no lower limbs edema. 
Doppler echocardiography revealed a dilated LV (68 mm 
and 74 mm in systole and diastole, respectively) and 
an enlarged left atrium (44 mm); the LVEF was 18%. 
Biochemical and hematological tests were normal.
Under the presumed cl inical diagnosis of 
idiopathic dilated cardiomyopathy, orthotopic cardiac 
transplantation was performed and the patient was put 
on immunosuppressive drugs: prednisone, cyclosporine, 
and mycophenolate mofetil. Post-operative thoracic 
computed tomography revealed bilateral hemothorax 
and pulmonary atelectasis but no lymphadenopathy or 
other pulmonary abnormalities.
The patient was regularly followed in the 
post-transplantation period and was doing well, with 
adequate function of the graft and no significant 
adverse events. Nevertheless, two and a half years 
after the transplantation, she died from acute heart 
failure in another hospital. No autopsy was performed.
PATHOLOGICAL EXAMINATION
The explanted heart weighed 450 g (mean reference 
value for a 60 kg female = 262 g), had a round shape, 
and both ventricles formed the apex. On the epicardial 
surface there was a moderate amount of fat, mainly in 
the anterior right ventricle (RV). The coronary arteries 
showed no obstruction, and only mild atherosclerotic 
lesions were seen. The RV and the right atrium were 
dilated. The LV showed moderate dilatation and the 
septum was arched into the RV. No intracavitary 
thrombi were seen. There were light-colored areas 
in the free LV wall and septum suggesting fibrosis 
(Figure 1A). A great amount of fat was encountered in 
the RV wall, mainly in the anterior, inferior, and lateral 
regions, with a diffuse and severely reduced width of 
the muscular layer, but there was no aneurysmatic 
formation (Figure 1B). In the anterior RV wall, almost 
all the muscle was replaced by fat.
The histologic examination included hematoxylin 
and eosin stain (H&E), Masson trichrome, periodic 
acid-Schiff (PAS), and Wade stain for acid-alcohol 
resistant bacilli. In the LV wall, there were multiple 
areas of fibrosis (Figure 2A); fatty tissue separating 
myocardial fascicles (Figure 2B); numerous epithelioid 
granulomas with multinucleated giant cells and no 
central necrosis (Figure 2C); and scattered interstitial, 
predominantly mononuclear, inflammatory infiltrates, 
with a significant number of eosinophils in some 
areas (Figure 2D). No infectious agents were found. 
The RV wall was almost completely replaced with 
fibrofatty tissue (Figure 3A). In the remaining few 
Figure 1. Gross pathology of the heart. A - LV showing 
wall thinning and a grey-whitish fibrous tissue spreading 
from the epicardium towards the myocardium; B - Severe 
fibrofatty replacement of the RV and the interventricular 
septum.
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layers of the RV myocardium, there were myocytes in 
degeneration along with inflammatory infiltrates and 
several well-formed granulomas with multinucleated 
giant cells and no central necrosis (Figure 3B). Some 
of the giant cells contained cytoplasmic basophilic 
structures of uncertain nature, surrounded by a clear 
halo (Figure 3C).
ANATOMIC DIAGNOSIS
Cardiac sarcoidosis with severe RV involvement.
CONFOCAL IMMUNOFLUORESCENCE ANALYSIS
The immunoreactive signal for the non-desmosomal 
protein N-cadherin (control protein) was strong and 
indistinguishable from the controls, indicating that 
the tissue samples were well-preserved and suitable 
for analysis (Figure 4A). The immunoreactive signal 
for the desmosomal protein plakoglobin was severely 
depressed at the cardiac intercalated disks compared 
to the controls (Figure 4B); the same occurred for the 
immunoreactive signal for desmoplakin (Figure 4C). 
The signal for plakophillin-2 was strong and was not 
different from the controls (Figure 4D). The desmin 
(Figure 5A) and the SAP97 (Figure 5B) signals were 
strong in a sarcomeric distribution, but were severely 
reduced at the intercalated disks in relation to the 
controls. The signal for the major gap junction protein 
Cx43 was strong but showed profound lateralization 
(Figure 5C). Specimens from three hearts with no 
evidence of disease were used as the controls.
DISCUSSION
Concerning the granulomatous myocarditis 
of uncertain origin, it is important to differentiate 
Figure 2. Photomicrography of the myocardium, LV histological analysis. A - Free wall with a great amount of 
subepicardial fibrous tissue penetrating muscular fascicles, and scattered, well-formed granulomas; B - Fatty tissue 
separating myocardial fascicles and moderate inflammatory infiltrate; C - Well-formed myocardial epithelioid 
granuloma with giant multinucleated cells and no necrosis; D - Inflammatory infiltrate with a significant number of 
eosinophils. H&E stain.
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between two anatomoclinical conditions: sarcoidosis 
and idiopathic giant cell myocarditis. Usually a 
systemic disease, but occasionally restricted to the 
heart, sarcoidosis seems to result from an abnormal 
immune response to different pathogenic stimuli in 
genetically susceptible hosts.1 Among such stimuli, 
some infectious agents are presumed to play a role 
as a trigger. Rather than being a distinct disease, 
sarcoidosis seems to be a final common pathway of 
several separate entities. There is an unquestionable 
family clustering and an increased risk (~5-fold) in 
siblings of affected individuals.2,3
Regarding cardiac sarcoidosis, most patients 
had little or no clinical evidence of dysfunction of 
any organ system other than the heart in a review of 
113 autopsies.4 In another study, in 84 consecutive 
autopsied patients with systemic disease, 23 (27%) 
had myocardial granulomas, which were clinically silent 
in 8 (35%), but in 15 (65%) there was a history of 
heart failure, arrhythmias and/or conduction defects. 
Arrhythmias and sudden cardiac death were markedly 
more common among those with gross and severe 
disease.5
There are no pathognomonic histopathologic 
findings that allow an unequivocal diagnosis of 
sarcoidosis, which makes the diagnosis, mainly in 
cases restricted to the heart, a clinical challenge – “an 
imperfect science, a hesitant art”.6,7 The asteroid bodies 
can be found in less than 10% of cases and are not 
specific, whereas the Schaumann bodies, although 
present in about 80% of cases, are also encountered in 
other granulomatous conditions, such as the infectious 
ones and berylliosis. However, the presence of these 
cytoplasmic inclusion bodies favors the diagnosis of 
sarcoidosis, since they occur more frequently in this 
disease. The granulomas of sarcoidosis are epithelioid, 
non-necrotizing, tight, and naked; there is more 
extensive fibrosis and a modest eosinophilic infiltrate. 
On the other hand, in idiopathic giant cell myocarditis 
– a disease that usually presents in a catastrophic way, 
with severe and subacute heart failure, and heralds a 
worse prognosis – the granulomas are not well-formed; 
myocyte necrosis is frequent; and there is widespread or 
serpiginous inflammation with giant cells, lymphocytes, 
and a remarkable number of eosinophils.8
Although LV is the affected chamber in the 
great majority of patients, predominant RV disease 
has been found in sarcoidosis as well. In such cases, 
the RV showed remarkable wall thinning, along 
with conspicuous muscular hypotrophy and fibrous 
or, eventually, fibrofatty replacement.9-11 Mainly in 
the latter situation, it is mandatory to perform the 
differential diagnosis with arrhythmogenic right 
ventricular cardiomyopathy (ARVC). Both conditions 
have very similar clinical aspects, so sarcoidosis might 
be considered a phenocopy of ARVC. Even the epsilon 
waves, a classical electrocardiographic sign of ARVC, 
were described in one case of sarcoidosis.12 Some 
Figure 3. Photomicrography of the myocardium, RV 
histological analysis. A - Extensive fibrofatty replacement 
of the wall with conspicuous thinning of the muscular 
layer; B - Granulomatous inflammation; C - Basophilic 
structure with a polyhedral shape and a clear halo in the 
cytoplasm of a giant cell. H&E stain.
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Figure 4. Representative confocal immunofluorescence images from the right and left ventricular myocardium of 
the patient and a control heart. A - Normal immunoreactive signal for the non-desmosomal protein N-cadherin 
(control used to judge the quality of the sample); B - Severely depressed immunoreactive signal for plakoglobin; 
C - Reduced immunoreactive signal for desmoplakin; D - Normal immunoreactive signal for plakophilin-2. LV = left 
ventricle; RV = right ventricle.
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characteristics should raise suspicion for cardiac 
sarcoidosis over ARVC: older age of symptoms 
onset, nonfamilial pattern of disease, PR interval 
prolongation, high-grade atrioventricular block, 
significant left ventricular dysfunction, myocardial 
delayed enhancement of the septum on magnetic 
resonance, and mediastinal lymphadenopathy.13 Clinical 
differentiation is important once sarcoidosis patients 
may benefit from treatment with glucocorticoids, but 
not ARVC patients.
ARVC, previously (and improperly) cal led 
arrhythmogenic right ventricular dysplasia, is an 
under-recognized entity with a broad clinical and 
pathological spectrum. It is a clinically and genetically 
heterogeneous progressive disorder of the heart 
muscle, which is associated with ventricular arrhythmias 
Figure 5. Representative confocal immunofluorescence images from the right and left ventricular myocardium of 
the patient and a control heart. A - Normal sarcomeric distribution, but severely reduced junctional immunoreactive 
signal for desmin; B - Normal sarcomeric distribution, but severely reduced junctional immunoreactive signal for 
SAP97; C - Strong but lateralized immunoreactive signal for Cx43. LV = left ventricle; RV = right ventricle.
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and the risk of sudden death, particularly in the 
young and in athletes.14 First described as a distinct 
heredofamilial disease by Giovanni Maria Lancisi 
in 1736, ARVC may be seen as a “paradigm of 
translational medicine”.15,16 In most cases, the RV 
is predominantly affected – hence the expression 
ARVC – but some degree of LV involvement, such as 
inflammation and myocyte degeneration, is present 
in up to 76% of cases, mainly in the posterior and 
lateral walls.17 In fact, the spectrum of the disease is 
wider than initially thought, with the identification of 
biventricular or even isolated LV forms in addition to 
the more frequent RV involvement. Based on these 
findings, the condition is increasingly being referred to 
simply as “arrhythmogenic cardiomyopathy”.14
In the early stage – the “concealed phase” – 
there is no gross structural abnormality, but the 
patients have a higher risk of sudden cardiac death 
from ventricular arrhythmias, mainly during exercise; 
histologically, there is inflammation and myocyte 
degeneration. Macroscopic structural abnormalities 
may develop sooner or later. They are characterized 
by ventricular wall thinning due to myocytes loss 
and fibrous or fibrofatty replacement, occasionally 
giving rise to aneurysms, and finally evolving to global 
ventricular dilatation. During this phase, there may be 
arrhythmic manifestations, intraventricular conduction 
abnormalities, repolarization delays and/or heart 
failure, and the clinical picture is indistinguishable from 
that found in other types of dilated cardiomyopathies.
The disease has a marked segmental pattern. 
Classically, it has been accepted that the RV inflow 
tract, the outflow tract, and the apex were the most 
affected areas, the so-called “triangle of dysplasia”. 
More recently, however, this concept has been 
challenged, and a different pattern of distribution – 
the epicardial subtricuspid region, the basal free RV 
wall, the LV lateral wall, but sparing the RV apex – was 
described as the “displacement of RV apex from the 
triangle of dysplasia”.18 This pattern would be useful 
in differentiating ARVC from other etiologies of heart 
disease, such as sarcoidosis and idiopathic dilated 
cardiomyopathy. The diagnosis of ARVC is not easy and 
there is no gold standard test or criterion, but a set of 
aspects should be considered. In 1994, an International 
Task Force proposed some criteria for the diagnosis 
of the disease; in 2010, those criteria were revised to 
improve sensitivity, mainly of the early forms, without 
reducing specificity.19
Although the pronounced fat deposition in ARVC 
is remarkable at heart examination, the amount of 
fat is the least reliable criterion for its diagnosis, and 
a thorough and detailed analysis is mandatory in 
order to avoid overdiagnosis. Inflammation, myocyte 
degeneration, and fibrofatty replacement are the 
distinguishing characteristics. Fat deposition in the heart 
is a well-known and common finding. The so-called 
adipositas cordis refers to fat accumulation in the 
epicardial surface, especially in the anterolateral 
surface of the RV and the interventricular furrows, 
mainly in obese women with hypertension and/or 
atherosclerotic coronary artery disease. There is a 
more or less clear distinction in the boundary between 
the fatty and the muscular layers, and the muscular 
wall thickness is preserved. In the so-called “fatty 
infiltration of the myocardium”, the RV is again the 
most commonly affected area, and three patterns of 
fat deposition have been described: (1) around vessels 
and nerves; (2) separating the myocardium into coarse 
bundles; and (3) separating the muscular fibers, which 
are then subject to regressive alterations. None of 
these conditions is usually associated with any clinical 
manifestations, and there are controversies about 
their pathological meaning. It is noteworthy that 
fatty tissue can reach up to 50% of the total heart 
weight; moreover, in normal hearts the thickness of 
the epicardial fat can reach up to 13.6 mm in the free 
wall of the RV.20,21
In our case, the presence of multiple well-formed 
granulomas with no central necrosis, in a patient who 
presented with heart failure progressing over a few 
years to the point of heart transplantation, suggested 
the diagnosis of cardiac sarcoidosis. No extracardiac 
manifestations of sarcoidosis were clinically identified, 
although an autopsy was not performed. Nevertheless, 
the severe involvement of the right ventricle, with 
conspicuous reduction in the muscular layer thickness 
and fibrofatty replacement, makes this a remarkable case 
of sarcoidosis masquerading as ARVC. The significant 
eosinophilic infiltrate observed in some areas of 
the myocardium was attributed to a presumptive 
hypersensitivity reaction to the pre-transplantation 
dobutamine infusion.22
ARVC is usually inherited as an autosomal 
dominant trait. Only 30-50% of patients have an 
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abnormal gene that has been identified as causing 
the disease, but this percentage is variable and ranges 
from 26% to 58%, with the higher percentage in 
patients with clinical familial disease.23 Mutations in 
the plakophilin-2 gene are more common, but they 
also have been found in desmoglein-2, desmocollin-2, 
desmoplakin, and plakoglobin, among others. 
However, the interpretation of an “abnormal gene” for 
ARVC must also take into consideration the probability 
that the gene identified as abnormal is indeed 
causative. Disease manifestation and progression is 
known to be affected by additional mutations (digenic 
or compound heterozygosity), otherwise benign 
polymorphisms in desmosomal genes, mutations in 
genes yet to be identified, and environmental factors, 
particularly exercise.
According to some authors, changes in the 
plakophilin-2 gene sequence have been found in cases 
of sudden unexpected death with negative autopsy in 
the same frequency as in ARVC cases, highlighting the 
arrhythmogenic effect of these mutations, even in the 
absence of fibrofatty, inflammatory or degenerative 
myocardial alterations.24 Other authors have found 
desmosomal mutations typically related to ARVC 
in idiopathic familial dilated cardiomyopathy.25,26 
These findings question the relationship between the 
morphological findings of ARVC and desmosomal 
mutations, and prompts a discussion of the basis on 
which the definition of ARVC should be made: classical 
morphological criteria or the presence of desmosomal 
protein gene mutations with different phenotypic 
manifestations?
The pathogenesis of ARVC is an evolving field, 
but the most accepted proposed mechanism is 
that impaired genetically determined desmosome 
functioning under conditions of mechanical stress 
(altered shear response without changes in cell-to-cell 
adhesion) is thought to cause myocyte detachment and 
death.27 The myocardial injury is usually accompanied 
by inflammation, with subsequent repair by fibrofatty 
replacement. It looks like disease progression might 
occur in bursts, the so-called “hot phases”, which are 
usually asymptomatic, but can sometimes present with 
arrhythmias and even chest pain.28 The desmosome 
has not only mechanical functions, responsible for 
maintaining the structural integrity of the myocardium 
by resisting shear forces, but also electrical and 
transcriptional functions. Because some of the 
desmosomal proteins (such as plakoglobin) play roles as 
structural proteins in cell-to-cell mechanical junctions 
and as signaling molecules, the pathogenesis of ARVC 
also might be related to altered nuclear signaling.29 
In fact, there is evidence that plakoglobin translocation 
to the nucleus could cause a myogenic to adipogenic 
switch in cardiac progenitor cells, due to the ability of 
plakoglobin to sequester T-cell / lymphoid-enhancing 
binding (Tcf/Lef) transcription factors, thus suppressing 
the pro-myogenic canonical Wnt/β-catenin signaling 
pathway.30-33 To explain the electrical instability, that 
is brought about even before structural abnormalities 
appear, current hypotheses implicate acute cell death, 
gap-junction remodeling, and ion-channel crosstalk, in 
addition to re-entry arrhythmias caused by fibrofatty 
replacement.14
Naxos disease, which is caused by a mutation in 
the plakoglobin gene, and Carvajal syndrome, which 
is caused by a mutation in the desmoplakin gene, 
are autosomal recessive cardiocutaneous syndromes 
that present with woolly hair, palmoplantar keratosis, 
and cardiomyopathy. In Carvajal syndrome, it was 
observed, in a so far single studied case by confocal 
immunofluorescence analysis, a normal sarcomeric 
distribution of desmin, the major constituent of 
intermediate filaments that interact with the C-terminal 
region of desmoplakin, but its absence at intercalated 
disks. In that case, it was also identified a C-terminal 
desmoplakin gene truncating mutation, and it was 
speculated that it could impair the interaction between 
the desmoplakin and the intermediate filaments of 
the cytoskeleton, leading to a cardiomyopathy with 
biventricular involvement.34 As in Carvajal syndrome, 
in our case confocal immunofluorescence analysis 
revealed a pattern of sarcomeric distribution of desmin, 
which was not detected at the intercalated disks (as in 
normal subjects), raising the question of whether there 
would be a truncating mutation in the C-terminal 
region of the desmoplakin protein. Unfortunately, as 
the patient had died from acute heart failure in another 
institution and no blood samples remained stored, 
genetic analysis could not be performed. 
Besides the sarcomeric distribution of desmin, 
other important confocal immunofluorescence findings 
were identified in our case. Like the immunoreactive 
signal for desmin, the SAP97 immunoreactive signal 
was strong in a sarcomeric distribution, but was 
severely reduced at the intercalated disks compared 
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to the controls. SAP97 is a MAGUK protein known 
to regulate the forward trafficking of sodium and 
potassium channel subunits. More recently, it has been 
shown that SAP97 holds a key role in the forward 
trafficking of plakoglobin to the cell membrane and 
that SAP97-mediated trafficking is critical in the disease 
pathway in ARVC.35,36 We also found a severe depression 
of the immunoreactive signal for plakoglobin at the 
intercalated disks. This finding was once considered 
to be a distinguishing feature of ARVC, in order to be 
proposed as a diagnostic test.37 Thereafter, however, it 
was demonstrated that the depressed immunoreactive 
signal for plakoglobin can also be seen in sarcoidosis 
and giant cell myocarditis, but not in lymphocytic 
myocarditis. It was hypothesized that inflammatory 
mechanisms would be implicated in plakoglobin 
redistribution from junctional to intracellular sites in 
ARVC and in granulomatous myocarditis, suggesting 
potential mechanistic links in the pathogenesis of 
those entities.38 Finally, we found that the Cx43 signal 
was normal and strong, but intensely lateralized 
on confocal immunofluorescence analysis, whereas 
in the normal heart control the Cx43 signal was 
observed only at the intercalated disks. Translocation 
of the immunoreactive signal for Cx43 from the 
junctional to the lateral myocyte membranes (termed 
“lateralization”) is a sign of adverse remodeling to the 
stress faced by the myocardium. Previous studies have 
revealed a diminished or normal Cx43 signal in ARVC 
cases, but no mention has been made of lateralization. 
However, downregulation or redistribution of Cx43 is a 
common finding in several forms of cardiomyopathies, 
such as hypertrophic, ischemic and idiopathic dilated, 
in some cases presenting a lateralized pattern, which 
makes this a nonspecific finding.39
To the best of our knowledge, only one case of 
ARVC and sarcoidosis association has been described 
so far.40 In that case, there was evidence of extracardiac 
sarcoidosis manifestations, and the diagnosis of ARVC 
was based on the finding of extensive RV fibrofatty 
replacement, with no other ancillary tests, as confocal 
immunofluorescence analysis.
The clinical diagnosis in our case was idiopathic 
dilated cardiomyopathy. In a series of 314 patients 
having undergone cardiac transplantation, clinical 
and post-transplantation morphological diagnoses 
were congruent in 87% of cases. However, all clinical 
sarcoidosis and ARVC diagnoses were missed in this 
series, highlighting the difficulty of the identification 
of these cardiomyopathies.41
Some patients with sarcoidosis present with 
refractory heart fa i lure and undergo cardiac 
transplantation. Besides the possible complications 
inherent to this procedure, there is a risk of sarcoidosis 
recurrence in the transplanted organ (2 out of 8 in a 
series of patients).42 However, patients with sarcoidosis 
undergoing orthotopic heart transplantation seem to 
have a better short- and intermediate-term survival 
than the majority of heart transplantation recipients.43 
Our patient died from acute heart failure two and 
a half years after transplantation. The exact cause 
could not be determined due to the rapid and fatal 
evolution, but it could have been due to rejection of 
the graft or recurrence of the original heart disease, 
since recurrence of sarcoidosis in the cardiac graft 
has been reported to occur as early as 24 weeks after 
transplantation.43
In conclusion, herein we present the case of a 
patient who underwent heart transplantation for cardiac 
sarcoidosis with severe RV involvement characterized 
by a markedly reduced width of the muscular layer and 
fibrofatty replacement. Prior to pathologic evaluation 
of the explanted heart, a presumptive diagnosis of 
idiopathic dilated cardiomyopathy was made. Confocal 
immunofluorescence analysis revealed a desmin 
sarcomeric distribution pattern, with no signal at 
the intercalated disks, a finding that was previously 
described in an 11-year-old girl with Carvajal syndrome 
bearing a desmoplakin gene truncating mutation at the 
C-terminal region. Although we have not been able to 
search for a genetic component, this case highlights 
the importance of the differential diagnosis among 
isolated cardiac sarcoidosis, ARVC and idiopathic 
dilated cardiomyopathy, which are clinical entities that 
appear to have more overlap than originally believed.
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